Press release
Lewy Body Dementia Treatment Market to Reach USD 13.32 Billion by 2034, Growing at 8.1% CAGR
The global Lewy body dementia treatment market size was valued at USD 6.13 billion in 2024. It is anticipated to generate an estimated revenue of USD 13.32 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust compound annual growth rate (CAGR) of 8.1% over the forecasted timeframe of 2025-2034.
Get Exclusive Sample Pages of This Report: https://www.polarismarketresearch.com/industry-analysis/lewy-body-dementia-treatment-market/request-for-sample
Market Introduction
Lewy body dementia (LBD) is the second most common form of dementia after Alzheimer's disease. It is characterized by the accumulation of abnormal protein deposits, known as Lewy bodies, in the brain's nerve cells. The protein deposits impact brain regions included, including cognition, memory, and movement. Cholinesterase inhibitors are commonly prescribed for LBD and they commonly operate by increasing the levels of chemical messengers in the brain known as neurotransmitters. These medicines assist in enhancing awareness and contemplation.
Approaches such as behavioral strategies can be tried out as people with this illness are not bothered by the visual hallucinations. For instance, many individuals with LBD experience visual hallucinations, though these are not always distressing to the patient. In such cases, the side effects of treatment may outweigh the hallucinations themselves. Creating a calm environment by reducing clutter and noise can make it easier for individuals with dementia to function.
Market Drivers
Growing Cases of LBDs: The growing cases of LBDs notably push the demand for efficient cures. As per the American Brain Foundation, LBD is identified as the second biggest natural cause of dementia in older people, impacting over 1.4 million persons in the US alone. This sizeable patient population highlights the urgent requirement for progressive therapeutic mediation, thus spiraling the Lewy body dementia treatment market size.
Progressions in Scientific Research: Advancements in scientific research and the commencement of clinical trials have been important in augmenting the therapeutic topography for LBDs. In 2022, the National Institutes of Health (NIH) granted USD 10.7 million permission to the Cleveland Clinic to improve a national research organization concentrated on enhancing LBD diagnosis and cure.
Request for a Discount on this Report Before Purchase: https://www.polarismarketresearch.com/industry-analysis/lewy-body-dementia-treatment-market/request-for-discount-pricing
Competitive Landscape
Product innovation remains a key strategy for many companies, prompting significant investment in research and development (R&D). Some of the key players currently operating in the market include:
AbbVie Inc.
AstraZeneca plc
Bristol-Myers Squibb Company
Eisai Co., Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited
UCB S.A.
Industry Developments in Lewy Body Dementia Treatment
In October 2022, Pfizer Inc. completed the acquisition of Biohaven Pharmaceuticals Inc. for USD 11.6 billion. This strategic move is intended to strengthen Pfizer's capabilities in delivering innovative treatment solutions worldwide. Biohaven, known for its focus on neurological disorders such as Parkinson's disease-a condition closely linked to Lewy body dementia-adds valuable expertise and therapeutic assets to Pfizer's portfolio.
Segmental Outlook
By Drug Type Outlook (Revenue - USD Billion, 2020-2034)
Modafinil
Cholinesterase Inhibitors
Benzodiazepine
Antipsychotic Drugs
Antidepressants
Carbidopa-Levodopa
By Indication Outlook (Revenue-USD Billion, 2020-2034)
Parkinson's Disease
Dementia with Lewy Bodies (DLB)
By Distribution Channel Outlook (Revenue-USD Billion, 2020-2034)
Drug Stores
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Explore The Complete Comprehensive Report Here: https://www.polarismarketresearch.com/industry-analysis/lewy-body-dementia-treatment-market
Regional Perspective
North America holds the largest market share due to a notable patient population, growing consciousness, and the obtainability of a progressive healthcare framework.
Asia Pacific is emerging as a rapidly growing market owing to an extensive and elderly population, growing healthcare disbursement, and elevated consciousness of dementia connected conditions.
More Trending Latest Reports by Polaris Market Research:
https://www.polarismarketresearch.com/industry-analysis/plasma-fractionation-market
https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-in-cancer-diagnostics-market
https://www.polarismarketresearch.com/industry-analysis/wearable-skin-adhesives-market
https://www.polarismarketresearch.com/industry-analysis/oral-irrigator-market
https://www.polarismarketresearch.com/industry-analysis/cell-counting-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lewy Body Dementia Treatment Market to Reach USD 13.32 Billion by 2034, Growing at 8.1% CAGR here
News-ID: 4019418 • Views: …
More Releases from Polaris Market Research and Consulting
In Situ Hybridization Market Size Set to Hit USD 3,015.57 Million by 2034, Growi …
Polaris Market Research has released new insights into the In Situ Hybridization market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 1,546.93 million and is anticipated to grow to USD 3,015.57 million by…
Next Generation Sequencing Sample Preparation Market Size Set to Hit USD 16.57 B …
Polaris Market Research has released new insights into the Next Generation Sequencing Sample Preparation market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 4.09 billion and is anticipated to grow to USD 16.57…
Plastic Welding Equipment Market Projected to Reach USD 2.69 Billion by 2034 , R …
Polaris Market Research announces the release of its latest study on the Plastic Welding Equipment market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at USD 1.60 billion in 2024 and is expected to reach USD…
DNA Manufacturing Market Projected to Reach USD 21.82 Billion by 2034, Registeri …
Polaris Market Research announces the release of its latest study on the DNA Manufacturing market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at USD 5.59 billion in 2024 and is expected to reach USD 21.82…
More Releases for Lewy
Lewy Body Dementia Market to Reach USD 9.4 Billion by 2034
Lewy Body Dementia (LBD) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases. It is caused by the abnormal accumulation of alpha-synuclein protein (Lewy bodies) in the brain, leading to cognitive decline, visual hallucinations, fluctuating alertness, REM sleep behavior disorder, and Parkinsonism symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71909
With aging populations and rising awareness, the LBD market is…
Lewy Body Dementia Market Forecast 2025-2034: Comprehensive Analysis And Growth …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Lewy Body Dementia Market?
In recent times, the market size for Lewy body dementia has witnessed substantial growth. It is projected to increase from $1.12 billion in 2024 to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic growth…
Lewy Body Disease Pipeline: 10+ Innovators Advancing Disease-Modifying and Sympt …
Lewy Body Disease (LBD), including dementia with Lewy bodies and Parkinson's disease dementia, is a complex neurodegenerative condition attracting the attention of over 10 key companies such as Cognition Therapeutics, Eli Lilly and Company, Athira Pharma, and NLS Pharmaceutics. The LBD pipeline features therapies targeting alpha-synuclein, neuroprotective agents, and symptomatic treatments that address cognition, motor symptoms, and neuropsychiatric complications. With no approved disease-modifying treatment, this pipeline represents a vital frontier…
Lewy Body Dementia Treatment Market Challenges: Growth, Share, Value, Trends and …
Lewy Body Dementia Treatment Market Size And Forecast by 2031
The LBD Therapy Market is expanding rapidly, driven by increasing consumer demand, technological advancements, and industry-wide innovation. According to top market research firms, businesses in the Neurodegenerative Disorder Treatment Market are prioritizing digital transformation, product development, and data-driven decision-making to stay competitive. With rising investments in automation and efficiency, the Dementia Care Market is evolving to meet changing customer preferences.…
Lewy Body Dementia Treatment Market Focuses on Advancements in Diagnosis and The …
Global Lewy Body Dementia Treatment Market, By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, and Modafinil), Application Type (Parkinson's Disease and Alzheimer's Disease), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies and Others) - Industry Trends and Forecast to 2031.
Data Bridge Market Research analyses that the Global Lewy Body Dementia Treatment Market which was USD 5.66 Billion in 2023…
Lewy Body Dementia Treatment Market Analysis, Trends & Forecast 2024-2033 | Grow …
The lewy body dementia treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2023 to $4.41 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to supportive care and family education, regulatory approvals and guideline, multidisciplinary care approaches, psychosocial and behavioral interventions, multidisciplinary care approaches..
The lewy body dementia treatment…
